fbpx
Medical Innovation Exchange

Lilly 'won't be discouraged' if others fail in Alzheimer's, neuroscience chief says

https://www.fiercebiotech.com/biotech/lillys-alzheimers-drug-stacks-behind-biogen-eisais-fdas-priority-review-lane

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.